These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 23879192)
1. The prognostic role of the new entity butterfly-like facial rash and cutaneous findings in patients with crimean congo haemorrhagic fever. Pancar GS; Duygu F; Kalkan G J Eur Acad Dermatol Venereol; 2013 Mar; ():. PubMed ID: 23879192 [TBL] [Abstract][Full Text] [Related]
2. Cutaneous Findings of Crimean-Congo Hemorrhagic Fever: a Study of 269 Cases. Duygu F; Sari T; Gunal O; Barut S; Atay A; Aytekin F Jpn J Infect Dis; 2018 Nov; 71(6):408-412. PubMed ID: 29962486 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of seroprevalence and clinical and laboratory findings of patients admitted to health institutions in Gümüşhane with suspicion of Crimean-Congo hemorrhagic fever. Gürbüz E; Ekici A; Ünlü AH; Yılmaz H Turk J Med Sci; 2021 Aug; 51(4):1825-1832. PubMed ID: 33754650 [TBL] [Abstract][Full Text] [Related]
4. A case of Crimean-Congo haemorrhagic fever with normal laboratory findings. Sari T; Hatipoglu CA Infez Med; 2014 Sep; 22(3):227-9. PubMed ID: 25269965 [TBL] [Abstract][Full Text] [Related]
5. Examination of the specific clinical symptoms and laboratory findings of Crimean-Congo hemorrhagic fever. Kilinc C; Gückan R; Capraz M; Varol K; Zengin E; Mengeloglu Z; Menekse E J Vector Borne Dis; 2016; 53(2):162-7. PubMed ID: 27353587 [TBL] [Abstract][Full Text] [Related]
6. Cytokine release syndrome in Crimean-Congo hemorrhagic fever: can IL-1 receptor antagonist levels be a guide in its treatment? Çelik N; Laloğlu E Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8934-8942. PubMed ID: 37782202 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey. Hatipoglu CA; Bulut C; Yetkin MA; Ertem GT; Erdinc FS; Kilic EK; Sari T; Kinikli S; Oral B; Demiroz AP Scand J Infect Dis; 2010 Jul; 42(6-7):516-21. PubMed ID: 20166862 [TBL] [Abstract][Full Text] [Related]
9. Crimean-Congo Hemorrhagic Fever (CCHF) in Afghanistan: A retrospective single center study. Qaderi S; Mardani M; Shah A; Shah J; Bazgir N; Sayad J; Ghandchi E; Samsami M; Bagherpour JZ Int J Infect Dis; 2021 Feb; 103():323-328. PubMed ID: 33278621 [TBL] [Abstract][Full Text] [Related]
10. Crimean-Congo haemorrhagic fever-induced liver injury: A systematic review and meta-analysis. Rathore SS; Manju AH; Wen Q; Sondhi M; Pydi R; Haddad I; Hasan J; Ali MA; Tousif S; Singh R; Muhammed AA; Ahmed NK; Patel DM Int J Clin Pract; 2021 Nov; 75(11):e14775. PubMed ID: 34480502 [TBL] [Abstract][Full Text] [Related]
11. Effects of platelet function on the haemorrhagic manifestations and mortality in Crimean-Congo haemorrhagic fever. Duygu F; Sari T; Celik H Infez Med; 2018 Dec; 26(4):341-346. PubMed ID: 30555138 [TBL] [Abstract][Full Text] [Related]
12. Treatment of Crimean-Congo Haemorrhagic Fever by Favipiravir in a Patient with Novel Coronavirus Co-Infection. Dülger AC; Yakarişik M; Uzun YE; Şahin AM Eur J Case Rep Intern Med; 2020; 7(12):002042. PubMed ID: 33457366 [TBL] [Abstract][Full Text] [Related]
13. Various clinical conditions can mimic Crimean-Congo hemorrhagic fever in pediatric patients in endemic regions. Kara SS; Kara D; Fettah A J Infect Public Health; 2016; 9(5):626-32. PubMed ID: 26868277 [TBL] [Abstract][Full Text] [Related]
14. Crimean-Congo hemorrhagic fever in children. Tezer H; Sucakli IA; Sayli TR; Celikel E; Yakut I; Kara A; Tunc B; Ergonul O J Clin Virol; 2010 Jul; 48(3):184-6. PubMed ID: 20444644 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions. Ozturk B; Tutuncu E; Kuscu F; Gurbuz Y; Sencan I; Tuzun H Int J Infect Dis; 2012 Feb; 16(2):e89-93. PubMed ID: 22154082 [TBL] [Abstract][Full Text] [Related]
16. [A Case of Simultaneous Acute Lymphoblastic Leukemia Diagnosis with Crimean-Congo Hemorrhagic Fever]. Çayıröz P; Çayıröz MU; Iltar U; Kurtoğlu E Mikrobiyol Bul; 2020 Apr; 54(2):326-333. PubMed ID: 32723287 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of Efficacy of Ribavirin on Laboratory Test and Severity Score in Crimean-Congo Hemorrhagic Fever in Children]. Karaaslan E; Çetin Ş Mikrobiyol Bul; 2021 Apr; 55(2):180-193. PubMed ID: 33882650 [TBL] [Abstract][Full Text] [Related]
18. Predictive epidemiological, clinical and laboratory parameters in the diagnosis of Crimean-Congo hemorrhagic fever. Kaygusuz TÖ; Tartar AS; Balin ŞÖ; Akbulut A; Demirdağ K Biomark Med; 2023 Jun; 17(11):533-540. PubMed ID: 37791843 [No Abstract] [Full Text] [Related]
19. Crimean-Congo Hemorrhagic Fever Case Series: a Chronology of Biochemical and Hematological Parameters. Amin S; Rahim F; Mahmood A; Gul H; Noor M; Zia A; Ali B; Wahab A; Khan U; Ul Haq F Cureus; 2022 Sep; 14(9):e29619. PubMed ID: 36321017 [TBL] [Abstract][Full Text] [Related]
20. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria. Yilmaz G; Koksal I; Topbas M; Yilmaz H; Aksoy F J Clin Virol; 2010 Apr; 47(4):361-5. PubMed ID: 20149724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]